Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) does not directly interact with apixaban in a pharmacokinetic sense, but the combination raises practical questions worth understanding before you start either medicine. Apixaban is an anticoagulant — it reduces the blood's ability to clot — and anything that affects how medicines are absorbed or how your body handles gastrointestinal stress can matter when you are on it. Mounjaro is a Prescription-Only Medicine that requires a clinical assessment before it is prescribed; your prescriber will weigh up your full medicine list, including apixaban, as part of that review. Learn more about how Mounjaro works before reading on if you want the broader background first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The concern circulating in patient forums is often stated as a blanket rule, that GLP-1 medicines like tirzepatide are incompatible with blood thinners. That isn't what the clinical evidence or the regulators say. What is true is that Mounjaro slows gastric emptying, and this mechanism raises a real but manageable question for anyone taking oral medicines where consistent absorption matters. Apixaban falls into that category. The clinical concern is not some chemical clash between the two molecules; it is about timing, gut transit and what happens to absorption when you are feeling nauseated or have a GI upset in the first weeks of treatment.
Understanding the distinction matters, because the conclusion is different depending on which version you believe. A blanket incompatibility would mean you cannot take both. The actual picture is more nuanced: with careful clinical oversight, plenty of people on anticoagulants are prescribed GLP-1 medicines, but it requires a prescriber who knows your full history. The tirzepatide overview page covers the general mechanism in detail if you want the science behind gastric emptying.
Apixaban is taken once or twice daily and is absorbed through the gut wall. Its anticoagulant effect depends on predictable plasma levels, too low and you lose stroke or clot protection; too high and bleeding risk increases. Mounjaro slows the rate at which the stomach empties its contents into the small intestine, where most oral drug absorption happens. In theory, this could delay the time it takes apixaban to reach peak levels, though the net amount absorbed may not change substantially in most people.
The more acute risk is indirect. Nausea, vomiting and diarrhoea are the most commonly reported side effects in the early weeks, described in the NHS tirzepatide medicine guide and in the product's SmPC. If you vomit shortly after taking apixaban, the dose may not have been fully absorbed. For most medicines that is inconvenient; for an anticoagulant prescribed to prevent stroke or deep vein thrombosis, a missed or partial dose carries real clinical weight. Your prescriber should know how you are responding to Mounjaro's gastrointestinal effects and may want to monitor your situation more closely in the first weeks. Some patients find it helps to build a simple morning routine, apixaban before the kettle boils, with enough time to let it settle before Mounjaro's injection-day nausea, if any, begins.
The question of what to do if you vomit after taking apixaban is one for your anticoagulant prescriber specifically, not something to manage by instinct. Our page on Mounjaro and rivaroxaban covers similar ground for readers on that DOAC.
When a prescriber at a service like nume reviews a consultation, they read your current medicine list carefully, not as a checkbox exercise but because interactions and clinical context genuinely shape the decision. Apixaban is prescribed for a reason: usually atrial fibrillation, a recent DVT or pulmonary embolism, or a mechanical heart valve. Those conditions carry their own risk profile. Adding a medicine that changes gut transit and can cause GI upset in the first month is a clinical decision, not a self-service one.
You should tell both your GP and your anticoagulant monitoring team that you are starting or considering Mounjaro. If your INR or anti-Xa levels are monitored, more frequent checks in the early titration phase are sensible. The MHRA's Yellow Card scheme is there for reporting any new or unexpected symptoms while on either medicine, it applies to patients as well as professionals, and Mounjaro's Black Triangle status means those reports actively shape what regulators know. You can also find general information about Mounjaro's safety profile (including pancreatitis symptoms and when to seek urgent help) on the nume FAQs. Context on weight-loss treatment costs, should that be useful, is on the Mounjaro price comparison page.
Mounjaro is a Prescription-Only Medicine. A clinical assessment by a GPhC-registered prescriber (reviewing your medical history, your current medicines and your circumstances) is the only route to a legitimate prescription. If you use nicotine products alongside your treatment, our guidance on Mounjaro and vaping is worth reading before your consultation. If you are on apixaban and want to explore weight management with Mounjaro, the right first step is a conversation with a qualified prescriber, rather than a search for the cheapest Mounjaro listing online.
Ready to have that conversation? Speak to our prescribers through a free consultation, reviewed the same day by a named clinician, with your full medical history in mind.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.